Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ulobetasol lotion - Sun Pharmaceutical Industries

Next Previous
Drug Profile

Ulobetasol lotion - Sun Pharmaceutical Industries

Alternative Names: Halobetasol propionate lotion- Sun Pharmaceutical Industries; HBP lotion- Sun Pharmaceutical Industries; Ultravate

Latest Information Update: 22 Oct 2020

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sun Pharmaceutical Industries
  • Class Anti-inflammatories; Antiallergics; Antipsoriatics; Corticosteroids; Skin disorder therapies; Small molecules
  • Mechanism of Action Phospholipase A2 inhibitors; Steroid receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Plaque psoriasis
  • No development reported Atopic dermatitis

Most Recent Events

  • 22 Oct 2020 No development reported - Phase-II for Atopic dermatitis (In adolescents, In children, In the elderly, In adults) in USA (Topical)
  • 09 May 2018 Sun Pharmaceutical Industries and MiCal Pharmaceuticals initiates litigation against Perrigo Company over ANDA submission in USA
  • 15 Feb 2018 Sun Pharmaceutical Industries Limited suspends patient enrolment in a phase II trial due to sponsor's decision in Atopic dermatitis (In children, In adolescents, In adults, In the elderly) in USA (Topical, Spray) (NCT03245385)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top